Evotec Investor
Evotec is a drug discovery alliance and development partnership rapidly progressing innovative product approaches with pharmaceutical and biotechnology companies, academics, patient advocacy groups, and venture capitalists. Drug discovery solutions are provided in the form of fee-for-service work, integrated drug discovery alliances, development partnerships, licencing of innovative drug candidates, and consulting arrangements.
Investors
.png)
Headquarters:
Hamburg,Hamburg,Germany,Europe
Employee Number:
1001-5000
Industry:
Cell & Gene Therapies
Number Of Exists:
2
Investor Type:
Private Equity Funds
Founded Date:
1993-01-01
Funding Status:
public